+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Peritoneal Dialysis Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797828
The global peritoneal dialysis market size attained a value of nearly USD 4.64 billion in 2022. The market is likely to grow at a CAGR of 6.4% during the forecast period of 2023-2031 to attain a value of USD 8.11 billion by 2031.

Peritoneal Dialysis Market: Introduction

Peritoneal dialysis (PD) is a type of dialysis therapy that filters and cleans the blood inside the body when the kidneys are no longer able to do so adequately. This method uses the lining of the abdomen, known as the peritoneal membrane, as a natural filter.

The process involves introducing a dialysis solution into the peritoneal cavity through a catheter. The solution absorbs waste products and excess fluids from the blood across the peritoneal membrane. After a set dwell time, the used solution, now containing the waste products, is drained out and replaced with fresh dialysis solution. This cycle is repeated multiple times a day.

There are two main types of peritoneal dialysis:
  • Continuous Ambulatory Peritoneal Dialysis (CAPD): In CAPD, the process is done manually by the patient, usually four or five times a day at home or work
  • Automated Peritoneal Dialysis (APD): In APD, a machine called a cycler performs the exchanges during the night while the patient sleeps
Peritoneal dialysis is mainly used to treat end-stage renal disease (ESRD) or kidney failure. It offers several advantages over traditional in-centre haemodialysis, such as greater flexibility and independence, the ability to dialyze at home or while traveling, and the absence of needles. For some patients, PD may also better preserve residual kidney function and offer a more continuous form of dialysis, more closely mimicking the kidneys' natural function.

Despite its benefits, peritoneal dialysis may not be suitable for everyone, including those who have had multiple abdominal surgeries, have certain types of vascular disease, or have an inability to care for themselves or lack of support at home.

Peritoneal Dialysis Market Segmentations

The market can be categorised into treatment type, product type, end user, treatment channel, and major region.

Market Breakup by Treatment Type

  • Continuous Ambulatory Dialysis Services
  • Automated Peritoneal Dialysis Services

Market Breakup by Product Type

  • Peritoneal Dialysis Solutions
  • Peritoneal Dialysis Devices
  • Peritoneal Dialysis Sets
  • Peritoneal Dialysis Catheters
  • Others Peritoneal Dialysis Products

Market Breakup by End User

  • Home- Based Dialysis
  • Dialysis Centres and Hospitals
  • Others

Market Breakup by Treatment Channel

  • Public
  • Private

Peritoneal Dialysis Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Peritoneal Dialysis Market Scenario

The global market is witnessing substantial growth, primarily driven by the increasing prevalence of end-stage renal disease (ESRD) and chronic kidney disease (CKD). The World Health Organization estimates that millions of people worldwide suffer from kidney diseases, with diabetes and hypertension being the leading causes. This surge in patient numbers necessitates an effective treatment method like peritoneal dialysis, thereby driving the market growth.

The peritoneal dialysis market's expansion is also bolstered by the increasing demand for home healthcare solutions. PD offers patients the flexibility to manage their dialysis treatment in the comfort of their homes, thereby reducing frequent hospital visits and related costs. This increased convenience and affordability make PD an attractive option for many patients and healthcare systems alike.

Technological advancements have been a key contributor to the growth of the PD market. The development of automated peritoneal dialysis (APD) machines, for instance, has enhanced the efficiency and ease of dialysis treatment at home. Companies are continuously investing in research and development to create more effective and user-friendly dialysis products, further propelling the market.

Regionally, North America holds a significant share of the global PD market due to the high prevalence of kidney diseases, advanced healthcare infrastructure, and widespread acceptance of home-based healthcare. However, the Asia Pacific region is anticipated to show rapid growth in the coming years due to its large patient population, growing awareness about kidney diseases, and improving healthcare facilities.

However, the market does face certain challenges. Lack of awareness about peritoneal dialysis, particularly in underdeveloped and developing regions, and the risk of peritonitis or infection associated with PD can hinder market growth.

Nevertheless, the overall future outlook for the peritoneal dialysis market remains positive, with the increasing prevalence of kidney diseases, ongoing technological advancements, and the growing trend of home-based healthcare expected to continue driving market growth.

Key Players in the Global Peritoneal Dialysis Market

The report gives an in-depth analysis of the key players involved in the peritoneal dialysis market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • DaVita Inc
  • Baxter
  • B. Braun Melsungen AG
  • Diaverum
  • Nipro
  • Nxstage Medical, Inc
  • Nikkiso Co., Ltd
  • Mar Cor Purification
  • Asahi Kasei Medical Co., Ltd
  • Rockwell Medical
  • Medtronic
  • Dialifegroup
  • JMS Co.Ltd
  • Atlantic Biomedical
  • 3M
  • Allmed Medical Care Holdings Limited
  • Isopure Corp
  • C. R. Bard, Inc.
Frequently Asked Questions about the Global Peritoneal Dialysis Market

What is the estimated value of the Global Peritoneal Dialysis Market?

The Global Peritoneal Dialysis Market was estimated to be valued at $4.93 Billion in 2023.

What is the growth rate of the Global Peritoneal Dialysis Market?

The growth rate of the Global Peritoneal Dialysis Market is 6.4%, with an estimated value of $8.11 Billion by 2031.

What is the forecasted size of the Global Peritoneal Dialysis Market?

The Global Peritoneal Dialysis Market is estimated to be worth $8.11 Billion by 2031.

Who are the key companies in the Global Peritoneal Dialysis Market?

Key companies in the Global Peritoneal Dialysis Market include Davita Inc., Baxter, B. Braun Melsungen AG, Diaverum, Nipro, Nxstage Medical, Inc., Nikkiso Co. Ltd., Mar Cor Purification, Asahi Kasei Medical Co. Ltd. and Rockwell Medical.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Peritoneal Dialysis Market Overview
3.1 Global Peritoneal Dialysis Market Historical Value (2016-2022)
3.2 Global Peritoneal Dialysis Market Forecast Value (2023-2031)
4 Global Peritoneal Dialysis Market Landscape
4.1 Peritoneal Dialysis: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Peritoneal Dialysis: Product Landscape
4.2.1 Analysis by Treatment Type
4.2.2 Analysis by Product Type
4.2.3 Analysis by End User
5 Global Peritoneal Dialysis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Peritoneal Dialysis Market Segmentation
6.1 Global Peritoneal Dialysis Market by Treatment Type
6.1.1 Market Overview
6.1.2 Continuous Ambulatory Dialysis Services
6.1.3 Automated Peritoneal Dialysis Services
6.2 Global Peritoneal Dialysis Market by Product Type
6.2.1 Market Overview
6.2.2 Peritoneal Dialysis Solutions
6.2.3 Peritoneal Dialysis Devices
6.2.4 Peritoneal Dialysis Sets
6.2.5 Peritoneal Dialysis Catheters
6.2.6 Others Peritoneal Dialysis Products
6.3 Global Peritoneal Dialysis Market by End User
6.3.1 Market Overview
6.3.2 Home- Based Dialysis
6.3.3 Dialysis Centers & Hospitals
6.3.4 Others
6.4 Global Peritoneal Dialysis Market by Treatment Channel
6.4.1 Market Overview
6.4.2 Public
6.4.3 Private
6.5 Global Peritoneal Dialysis Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Peritoneal Dialysis Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Peritoneal Dialysis Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Peritoneal Dialysis Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Peritoneal Dialysis Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Peritoneal Dialysis Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 DaVita Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Baxter
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 B. Braun Melsungen AG
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Diaverum
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Nipro
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Nxstage Medical, Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Nikkiso Co., Ltd.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Mar Cor Purification
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Asahi Kasei Medical Co., Ltd.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Rockwell Medical
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Medtronic
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Dialifegroup
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 JMS Co.Ltd.
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Atlantic Biomedical
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 3M
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
18.16 Allmed Medical Care Holdings Limited.
18.16.1 Financial Analysis
18.16.2 Product Portfolio
18.16.3 Demographic Reach and Achievements
18.16.4 Mergers and Acquisitions
18.16.5 Certifications
18.17 Isopure Corp.
18.17.1 Financial Analysis
18.17.2 Product Portfolio
18.17.3 Demographic Reach and Achievements
18.17.4 Mergers and Acquisitions
18.17.5 Certifications
18.18 C. R. Bard, Inc.
18.18.1 Financial Analysis
18.18.2 Product Portfolio
18.18.3 Demographic Reach and Achievements
18.18.4 Mergers and Acquisitions
18.18.5 Certifications
19 Peritoneal Dialysis Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket

Companies Mentioned

  • Davita Inc.
  • Baxter
  • B. Braun Melsungen AG
  • Diaverum
  • Nipro
  • Nxstage Medical, Inc.
  • Nikkiso Co. Ltd.
  • Mar Cor Purification
  • Asahi Kasei Medical Co. Ltd.
  • Rockwell Medical
  • Medtronic
  • Dialifegroup
  • Jms Co.Ltd.
  • Atlantic Biomedical
  • 3M
  • Allmed Medical Care Holdings Limited.
  • Isopure Corp.
  • C. R. Bard, Inc.

Methodology

Loading
LOADING...